These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2042556)

  • 21. Red tape hampers FDA as illegal prescription-drug importation booms.
    Med Health; 2005 Nov; 59(42):1, 6. PubMed ID: 16320970
    [No Abstract]   [Full Text] [Related]  

  • 22. New drugs: the AMA and the FDA.
    Appel JZ
    Ann Allergy; 1966 Jul; 24(7):333-6. PubMed ID: 5941864
    [No Abstract]   [Full Text] [Related]  

  • 23. Significant FDA approvals in 1995.
    Rheinstein PH
    Am Fam Physician; 1996 Apr; 53(5):1871-4. PubMed ID: 8623703
    [No Abstract]   [Full Text] [Related]  

  • 24. FDA new drug approvals in 2003.
    Wynn RL
    Gen Dent; 2004; 52(4):294-8, 300. PubMed ID: 15366292
    [No Abstract]   [Full Text] [Related]  

  • 25. The FDA and Helsinki.
    Rennie S
    Hastings Cent Rep; 2009; 39(3):49. PubMed ID: 19537622
    [No Abstract]   [Full Text] [Related]  

  • 26. FDA fights fake meds online.
    Ruder K
    Diabetes Forecast; 2007 Aug; 60(9):24. PubMed ID: 17767382
    [No Abstract]   [Full Text] [Related]  

  • 27. Significant FDA approvals in 2001.
    McGinnis TJ
    Am Fam Physician; 2002 Jun; 65(11):2377-8, 2380, 2383. PubMed ID: 12074535
    [No Abstract]   [Full Text] [Related]  

  • 28. Change in FDA definition of serious adverse drug event.
    Bader RL
    Am J Hosp Pharm; 1989 Jun; 46(6):1132. PubMed ID: 2750762
    [No Abstract]   [Full Text] [Related]  

  • 29. Significant FDA approvals in 1997.
    Rheinstein PH; Akbari B
    Am Fam Physician; 1998 Jun; 57(11):2865-8. PubMed ID: 9636343
    [No Abstract]   [Full Text] [Related]  

  • 30. The FDA and the fight against terrorism.
    Meadows M
    FDA Consum; 2004; 38(1):20-7. PubMed ID: 15032200
    [No Abstract]   [Full Text] [Related]  

  • 31. FDA announces initiative to curb counterfeit drugs.
    FDA Consum; 2003; 37(5):6. PubMed ID: 14666893
    [No Abstract]   [Full Text] [Related]  

  • 32. FDA drug approvals from 1994 to 1995.
    Wynn RL
    Gen Dent; 1996; 44(2):114, 116, 118. PubMed ID: 8690259
    [No Abstract]   [Full Text] [Related]  

  • 33. FDA drug approvals in 1993-94.
    Wynn RL
    Gen Dent; 1995; 43(1):12, 14. PubMed ID: 7758913
    [No Abstract]   [Full Text] [Related]  

  • 34. FDA-USP drug product problem reporting program--an update.
    Wheatley LS
    Hosp Formul; 1979 Mar; 14(3):359-60, 365. PubMed ID: 10316797
    [No Abstract]   [Full Text] [Related]  

  • 35. FDA new drug approvals in 2005.
    Wynn RL
    Gen Dent; 2006; 54(4):230-3. PubMed ID: 16903192
    [No Abstract]   [Full Text] [Related]  

  • 36. FDA new drug approvals in 2007.
    Wynn RL
    Gen Dent; 2008; 56(6):506-10. PubMed ID: 18810906
    [No Abstract]   [Full Text] [Related]  

  • 37. FDA new drug approvals in 2004.
    Wynn RL
    Gen Dent; 2005; 53(4):246-8. PubMed ID: 16158789
    [No Abstract]   [Full Text] [Related]  

  • 38. FDA new drug approvals in 2006.
    Wynn RL
    Gen Dent; 2007; 55(4):275-9. PubMed ID: 17682633
    [No Abstract]   [Full Text] [Related]  

  • 39. FDA reorganization.
    Weissinger J
    J Parenter Sci Technol; 1988; 42(4):122-6. PubMed ID: 3054036
    [No Abstract]   [Full Text] [Related]  

  • 40. FDA implementation of standards developed by the International Conference on Harmonisation.
    Booth PM
    Food Drug Law J; 1997; 52(2):203-23. PubMed ID: 10557561
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.